Matthias Mann obtained his PhD in chemical engineering at Yale, contributing to the Nobel Prize for his supervisor John Fenn for the development of electrospray ionization. Currently, he heads the Proteomics and Signal Transduction department at the Max-Planck Institute of Biochemistry in Munich, while also directing the Proteomics Program at the Center for Protein Research at Copenhagen University.
As a pioneer in his field, Dr. Mann has spearheaded groundbreaking technological advances and computational workflows, emphasizing translational research. His team increasingly focuses on clinically relevant questions, exploring body fluid proteomics, single-cell tissue heterogeneity, signaling, and post-translational modifications. With over 850 publications and an h-index of 260, Dr. Mann is highly cited, earning accolades like the Otto-Warburg Medal, Germany's Leibniz Prize, the Körber European Science Prize, the Louis-Jeantet Foundation Prize for Medicine, and 'The Order of Dannebrog Knights Cross' from the Queen of Denmark.